Stay updated on Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2, and the date has changed from April 1, 2025, to April 27, 2025.SummaryDifference0.6%
- Check46 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase.SummaryDifference0.9%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check103 days agoChange DetectedThe date has been updated from February 3, 2025, to February 11, 2025.SummaryDifference0.3%
Stay in the know with updates to Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Nasal Spray in Treatment-Resistant Depression Clinical Trial page.